First Manhattan
OPRX icon

First Manhattan’s OptimizeRx OPRX Stock Holding History

First Manhattan’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-70
Closed -$1K – 1763
2022
Q3 		$1K Hold
70
– – ﹤0.01% 1472
2022
Q2 		$1K Hold
70
– – ﹤0.01% 1496
2022
Q1 		$2K Hold
70
– – ﹤0.01% 1488
2021
Q4 		$4K Hold
70
– – ﹤0.01% 1404
2021
Q3 		$5K Hold
70
– – ﹤0.01% 1393
2021
Q2 		$4K Hold
70
– – ﹤0.01% 1437
2021
Q1 		$3K Buy
+70
New +$3.38K ﹤0.01% 1400

Other funds holding OPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $549M AUM 179.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Manhattan's OPRX Position: Q4 2022 in Review

First Manhattan sold out of OptimizeRx (OPRX) in Q4 2022, closing a stake of 70 shares — an estimated $1K sold.

First Manhattan first reported a position in OPRX in Q1 2021 and held it in 7 quarters. The position peaked at $5K in Q3 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q4 2022.

  • First Manhattan reported no remaining OptimizeRx position as of Q4 2022 after selling out during the quarter.
  • First Manhattan sold 70 OptimizeRx shares in Q4 2022, an estimated $1K.
  • First Manhattan first reported a position in OptimizeRx in Q1 2021 and held it in 7 quarters.
  • First Manhattan's OptimizeRx position peaked at $5K in Q3 2021.
  • 128 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2022.

Based on First Manhattan's 13F filing for Q4 2022, filed 14 Feb 2023.